Pluristem Therapeutics Inc. said Tuesday the Food and Drug Administration suspended a clinical trial of one of its stem cell therapies, sending the company's shares lower.
http://www.news.net/article/315115/Health+%26+Science/?
http://www.news.net/article/315115/Health+%26+Science/?
No comments:
Post a Comment